Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "666c09b805b00e1ad41ca790",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Topiramate 50mg",
"description": "TP MATE 50 \nTopiramate (50mg)\nIntroduction:\nTP MATE 50 contains Topiramate, a versatile anticonvulsant and migraine prophylactic medication. With a dosage strength of 50mg, TP MATE 50 is designed to manage seizures in epilepsy and prevent migraines, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\nAnticonvulsant Action:\nTP MATE 50 is highly effective in treating various types of seizures, including partial-onset seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. It stabilizes neuronal activity by enhancing GABAergic transmission, blocking sodium channels, and inhibiting glutamate activity.\nMigraine Prophylaxis:\n\nTopiramate is widely used for preventing migraines. By modulating neurotransmitter activity, TP MATE 50 reduces the frequency and severity of migraine attacks, helping patients manage their condition and improve their daily functioning.\nWeight Management:\n\nAn added benefit of TP MATE 50 is its potential to assist with weight loss. Unlike many anticonvulsants, Topiramate may lead to weight reduction, which can be beneficial for patients concerned about weight gain associated with other medications.\nMood Stabilization:\n\nTopiramate has mood-stabilizing properties, making it useful for patients with coexisting mood disorders such as bipolar disorder. It helps in stabilizing mood swings and reducing symptoms of anxiety and depression.\nWell-Tolerated and Safe:\n\nTP MATE 50 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and migraines.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of TP MATE 50 for adults with epilepsy typically starts at a low dose, gradually increasing to reduce the risk of side effects. A common starting dose is 25-50mg per day, increasing weekly by 25-50mg until the effective dose is reached. The usual maintenance dose ranges from 200-400mg per day, divided into two doses.\nInitial Dosage for Migraine Prophylaxis:\n\nFor migraine prevention, the initial dose is 25mg taken once daily, usually at night. The dose may be increased weekly by 25mg, up to a recommended dose of 50-100mg per day, divided into two doses.\nAdministration Instructions:\n\nTP MATE 50 tablets should be taken orally with or without food. It is important to maintain consistent dosing schedules to ensure stable therapeutic levels.\nContinued Monitoring:\n\nRegular monitoring of seizure frequency, migraine attacks, and potential side effects is essential during TP MATE 50 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \n",
"price": 92.0,
"discountamount": 28.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"day",
"life",
"food",
"50mg",
"25mg",
"risk",
"EMAIL",
"night",
"option",
"adults",
"anxiety",
"quality",
"symptoms",
"severity",
"50-100mg",
"low dose",
"epilepsy",
"patients",
"Benefits",
"200-400mg",
"two doses",
"condition",
"migraines",
"Topiramate",
"depression",
"mood swings",
"weight gain",
"weight loss",
"information",
"Key Features",
"sterispharma",
"Introduction",
"initial dose",
"sterisonline",
"CALL/WHATSAPP",
"added benefit",
"various types",
"mood disorders",
"patient safety",
"Initial Dosage",
"effective dose",
"sodium channels",
"dosage strength",
"migraine attacks",
"bipolar disorder",
"weight reduction",
"neuronal activity",
"seizure frequency",
"daily functioning",
"other medications",
"Weight Management",
"Regular monitoring",
"Mood Stabilization",
"TP MATE 50 therapy",
"glutamate activity",
"TP MATE 50 tablets",
"migraine prevention",
"long-term management",
"Migraine Prophylaxis",
"Continued Monitoring",
"common starting dose",
"many anticonvulsants",
"therapeutic efficacy",
"Anticonvulsant Action",
"usual maintenance dose",
"potential side effects",
"partial-onset seizures",
"GABAergic transmission",
"Lennox-Gastaut syndrome",
"favorable safety profile",
"versatile anticonvulsant",
"neurotransmitter activity",
"stable therapeutic levels",
"Administration Instructions",
"mood-stabilizing properties",
"consistent dosing schedules",
"migraine prophylactic medication",
"generalized tonic-clonic seizures"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1905,
"imageuri": "https://productimages.withfloats.com/actual/666c09bbf068be46bdec8995.png",
"tileimageuri": "https://productimages.withfloats.com/tile/666c09bbf068be46bdec8995.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-14T09:13:28.046Z",
"updatedon": "2026-03-12T11:58:29.217Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/topiramate-50mg/1905",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TP MATE 50 ",
"category": "NEUROLOGY RANGE",
"tags": [
"TP MATE 50",
"",
"Topiramate (50mg)",
"topiramate uses",
"topiramate 50 mg",
"topiramate side effects",
"topiramate side effects weight loss"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "69f1f2ab0401258bafb82cd7",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 500 mg Tablets",
"description": "Managing type 2 diabetes effectively often requires a combination of medicines that work together to control blood sugar levels. DAPAVILDA MET 10/100/500 is a powerful triple-combination tablet formulated with Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 500 mg Tablets. This advanced formulation is designed to help adults with type 2 diabetes maintain better glucose control, improve insulin response, and support overall metabolic health.\n\nIf you are looking for a trusted diabetes management tablet, DAPAVILDA MET 10/100/500 offers a convenient once-daily option under medical supervision.\n\nWhat is DAPAVILDA MET 10/100/500?\n\nDAPAVILDA MET 10/100/500 is a combination medicine used to treat Type 2 Diabetes Mellitus when diet, exercise, or single-drug therapy is not enough to control blood sugar. It contains three clinically proven ingredients:\n\nDapagliflozin 10 mg – Helps remove excess sugar through urine.\nVildagliptin SR 100 mg – Enhances insulin secretion and reduces glucagon release.\nMetformin SR 500 mg – Reduces glucose production in the liver and improves insulin sensitivity.\n\nThis triple-action therapy helps patients achieve better glycemic control and reduces diabetes-related complications.\n\nHow DAPAVILDA MET 10/100/500 Works\n1. Dapagliflozin 10 mg\n\nDapagliflozin belongs to the SGLT2 inhibitor class. It works by blocking glucose reabsorption in the kidneys, allowing excess sugar to pass out through urine. This helps lower blood sugar naturally.\n\n2. Vildagliptin SR 100 mg\n\nVildagliptin is a DPP-4 inhibitor that increases incretin hormone levels. These hormones stimulate insulin release after meals and reduce unnecessary glucose production.\n\n3. Metformin SR 500 mg\n\nMetformin is one of the most trusted diabetes medicines. It decreases glucose production in the liver and improves the body's response to insulin.\n\nTogether, these ingredients provide comprehensive blood sugar management throughout the day.\n\nUses of DAPAVILDA MET 10/100/500\n\nDAPAVILDA MET 10/100/500 Tablets are primarily used for:\n\n✔ Type 2 Diabetes Mellitus\n\nHelps manage high blood sugar levels in adults with type 2 diabetes.\n\n✔ Poorly Controlled Diabetes\n\nUseful when blood sugar remains high despite lifestyle changes or single/dual therapy.\n\n✔ Reduction of HbA1c Levels\n\nSupports long-term sugar control and helps reduce HbA1c.\n\n✔ Weight Management Support\n\nDapagliflozin may assist in mild weight reduction in some diabetic patients.\n\n✔ Improved Metabolic Health\n\nHelps improve insulin sensitivity and glucose utilization.\n\nKey Benefits of DAPAVILDA MET 10/100/500\n1. Triple Combination Formula\n\nThree effective medicines in one tablet for better sugar control.\n\n2. Better Fasting and Post-Meal Sugar Control\n\nHelps control both fasting blood sugar and postprandial spikes.\n\n3. Convenient Once Daily Dosage\n\nSustained release formula supports long-lasting action.\n\n4. Supports Weight Balance\n\nMay help reduce calorie overload through urinary glucose excretion.\n\n5. Helps Lower Risk of Diabetes Complications\n\nGood sugar control may reduce risk of kidney, nerve, eye, and heart problems.\n\n6. Improves Insulin Function\n\nSupports natural insulin release when needed.\n\nWho Can Use DAPAVILDA MET 10/100/500?\n\nThis medicine may be prescribed for:\n\nAdults with type 2 diabetes\nPatients needing triple-drug therapy\nOverweight diabetic individuals\nPatients with uncontrolled HbA1c\nIndividuals requiring convenient once-daily medication\n\nAlways use only after doctor consultation.\n\nRecommended Dosage\n\nThe dosage of DAPAVILDA MET 10/100/500 should be decided by a physician depending on:\n\nBlood sugar levels\nHbA1c results\nKidney function\nExisting medications\nOverall health condition\nGeneral Advice:\nTake with food to reduce stomach upset.\nSwallow whole with water.\nDo not crush or chew SR tablet.\nTake at the same time daily.\nSide Effects of DAPAVILDA MET 10/100/500\n\nLike all medicines, some users may experience mild side effects.\n\nCommon Side Effects\nNausea\nStomach discomfort\nFrequent urination\nHeadache\nLoose stools\nDizziness\nLow appetite\nLess Common Side Effects\nUrinary tract infection\nGenital fungal infection\nDehydration\nWeakness\nSerious Side Effects (Need Immediate Medical Help)\nSevere low sugar (if used with insulin/sulfonylureas)\nLactic acidosis (rare)\nAllergic reaction\nSevere dehydration\nKidney problems\n\nIf unusual symptoms appear, contact a doctor immediately.\n\nPrecautions and Warnings\n\nBefore using DAPAVILDA MET 10/100/500, inform your doctor if you have:\n\nKidney disease\nLiver disease\nHeart problems\nFrequent urinary infections\nHistory of pancreatitis\nAlcohol dependency\nPregnancy or breastfeeding\nImportant:\n\nStay hydrated while taking dapagliflozin-containing medicines.\n\nLifestyle Tips for Better Results\n\nMedicine works best with healthy habits:\n\n✔ Follow a Diabetic Diet\n\nReduce sugar, refined carbs, and oily foods.\n\n✔ Exercise Daily\n\nAt least 30 minutes walking or physical activity.\n\n✔ Monitor Blood Sugar\n\nCheck regularly as advised.\n\n✔ Stay Hydrated\n\nEspecially important with dapagliflozin.\n\n✔ Take Medicine Regularly\n\nDo not skip doses.\n\nWhy Choose DAPAVILDA MET 10/100/500?\n\nPatients and doctors prefer DAPAVILDA MET 10/100/500 because:\n\nTrusted triple therapy\nEffective glucose lowering\nSustained release convenience\nBetter compliance with one tablet\nSuitable for long-term diabetes management under supervision\nStorage Instructions\nStore in a cool, dry place\nKeep away from sunlight\nKeep out of reach of children\nStore below recommended temperature\nConclusion\n\nDAPAVILDA MET 10/100/500 containing Dapagliflozin 10 mg, Vildagliptin SR 100 mg and Metformin SR 500 mg Tablets is a highly effective triple-combination treatment for adults with type 2 diabetes. It helps lower blood sugar, improve insulin response, support weight control, and reduce long-term diabetes risks.",
"price": 325.0,
"discountamount": 98.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2393,
"imageuri": "https://productimages.withfloats.com/actual/69f1f2adf974f5424d3a55fa.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69f1f2adf974f5424d3a55fa.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-04-29T11:59:39.204Z",
"updatedon": "2026-04-29T11:59:39.204Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-10-mg-vildagliptin-sr-100-mg-and-metformin-sr-500-mg-tablets/2393",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "DAPAVILDA MET 10/100/500",
"category": "DIABETIC RANGE",
"tags": [
"Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 500 mg Tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "69d6115048622857aafcb373",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "sitagliptin 50 mg + dapagliflozin 5 mg",
"description": "Managing type 2 diabetes effectively requires a balanced approach that includes medication, diet, and lifestyle changes. ST-Gliptin Dapa, a powerful dual-combination therapy containing Dapagliflozin 5 mg and Sitagliptin Phosphate 50 mg, is designed to provide effective glycemic control for adults suffering from type 2 diabetes mellitus.\n\nThis innovative formulation works through two complementary mechanisms to help regulate blood sugar levels, reduce glucose reabsorption, and improve insulin response, making it a reliable choice for patients who need combination therapy.\n\nHow ST-Gliptin Dapa Works\n\nST-Gliptin Dapa combines two well-established antidiabetic agents that target different pathways in glucose metabolism:\n\nDapagliflozin belongs to the SGLT2 inhibitor class. It works by preventing glucose reabsorption in the kidneys, allowing excess sugar to be excreted through urine. This helps lower blood sugar levels and also supports mild weight loss.\nSitagliptin phosphate is a DPP-4 inhibitor that increases incretin hormone levels. These hormones help stimulate insulin release after meals and reduce glucagon secretion, leading to better postprandial glucose control.\n\nTogether, these two medications provide comprehensive blood sugar control throughout the day, especially in patients who are not achieving adequate results with a single drug.\n\nUses of ST-Gliptin Dapa\n\nST-Gliptin Dapa is prescribed for the following:\n\nManagement of Type 2 Diabetes Mellitus\nPatients with inadequate control on monotherapy\nReducing fasting and post-meal blood glucose levels\nImproving insulin secretion and sensitivity\nSupporting overall metabolic balance\n\nIt is usually recommended along with a proper diet and regular physical activity to achieve optimal results.\n\nKey Benefits of ST-Gliptin Dapa\n1. Dual Mechanism for Better Control\n\nThis combination works on both kidney and hormonal pathways, ensuring effective and sustained glucose reduction.\n\n2. Improved Glycemic Stability\n\nHelps reduce both fasting and postprandial blood sugar spikes, offering balanced control throughout the day.\n\n3. Weight Management Support\n\nDapagliflozin promotes glucose excretion, which can lead to modest weight loss, beneficial for overweight diabetic patients.\n\n4. Low Risk of Hypoglycemia\n\nCompared to insulin or sulfonylureas, this combination has a lower risk of causing hypoglycemia, making it safer for long-term use.\n\n5. Cardiovascular and Renal Benefits\n\nSGLT2 inhibitors like dapagliflozin are known to provide additional benefits for heart and kidney health when used under medical supervision.\n\n6. Enhanced Patient Compliance\n\nA fixed-dose combination reduces pill burden, making it easier for patients to follow their treatment plan consistently.\n\nDosage and Administration\nTake ST-Gliptin Dapa as prescribed by your healthcare provider\nTypically taken once daily, with or without food\nSwallow the tablet whole with water\nDo not skip doses or double up if a dose is missed\n\nAlways follow your doctor’s instructions for dosage adjustments based on your condition.\n\nSide Effects of ST-Gliptin Dapa\n\nLike all medications, ST-Gliptin Dapa may cause some side effects. Most are mild and manageable.\n\nCommon Side Effects\nFrequent urination\nThirst or dehydration\nHeadache\nNasopharyngitis (cold-like symptoms)\nMild gastrointestinal discomfort\nSerious Side Effects (Rare)\nUrinary tract infections\nGenital fungal infections\nPancreatitis (associated with DPP-4 inhibitors)\nKidney function changes\nSevere allergic reactions\n\nIf you experience any unusual or severe symptoms, seek medical attention immediately.\n\nPrecautions and Warnings\nNot recommended for patients with severe kidney impairment\nUse cautiously in elderly patients\nMaintain proper hydration to avoid dehydration\nInform your doctor about any existing liver, kidney, or heart conditions\nAvoid excessive alcohol consumption\n\nPregnant and breastfeeding women should consult a doctor before using this medication.\n\nWho Should Use ST-Gliptin Dapa?\n\nThis medication is suitable for:\n\nAdults diagnosed with Type 2 Diabetes\nPatients needing dual therapy for better control\nIndividuals who are overweight or have insulin resistance\nPatients who are not achieving targets with a single medication\nStorage Instructions\nStore in a cool and dry place\nKeep away from direct sunlight and moisture\nKeep out of reach of children\nConclusion\n\nST-Gliptin Dapa is a modern and effective dual-combination therapy that offers a comprehensive solution for managing type 2 diabetes. With the combined action of Dapagliflozin 5 mg and Sitagliptin Phosphate 50 mg, it targets multiple pathways involved in glucose regulation, helping patients achieve better glycemic control.",
"price": 290.0,
"discountamount": 87.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2370,
"imageuri": "https://productimages.withfloats.com/actual/69d61153b9380b73ede65348.jpg",
"tileimageuri": "https://productimages.withfloats.com/tile/69d61153b9380b73ede65348.jpg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-04-08T08:26:56.108Z",
"updatedon": "2026-05-04T10:05:22.561Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//sitagliptin-50-mg-dapagliflozin-5-mg/2370",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ST- GLIPTIN DAPA 50/5",
"category": "DIABETIC RANGE",
"tags": [
"dapagliflozin sitagliptin phosphate tablets",
"dapagliflozin sitagliptin phosphate",
"Sitagliptin 50 Mg + Dapagliflozin 5 Mg",
"dapagliflozin 5 mg sitagliptin 50 mg uses",
"Sitagliptin 50 Mg + Dapagliflozin 5 Mg side effects",
"dapagliflozin 5 mg sitagliptin 50 mg price in india",
"buy sitagliptin 50 mg dapagliflozin 5 mg tablets",
"sitagliptin dapagliflozin tablets wholesale price",
"sitagliptin 50 mg + dapagliflozin 5 mg tablets",
"dapagliflozin sitagliptin tablets bulk order"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "69d4f4af8538099a3d49a36b",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Dapagliflozin 10 mg,Teneligliptin 20 mg & Metformin Hydrochloride 500 mg (Extended Release) Tablets",
"description": "Managing type 2 diabetes effectively requires a combination of the right medication, lifestyle changes, and continuous monitoring. GLIDAPA TENMET 500, a powerful triple-combination tablet containing Dapagliflozin (10 mg), Teneligliptin (20 mg), and Metformin Hydrochloride (500 mg), is designed to provide comprehensive glycemic control for individuals suffering from type 2 diabetes mellitus.\n\nThis advanced formulation works through multiple mechanisms to regulate blood sugar levels, improve insulin sensitivity, and reduce glucose production, making it an ideal solution for patients who require combination therapy.\n\nHow GLIDAPA TENMET 500 Works\n\nGLIDAPA TENMET 500 combines three well-established antidiabetic agents, each targeting different pathways:\n\nDapagliflozin works by inhibiting SGLT2 receptors in the kidneys, promoting the excretion of excess glucose through urine.\nTeneligliptin increases incretin hormone levels, which stimulate insulin secretion and decrease glucagon release after meals.\nMetformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues.\n\nTogether, this triple-action formula ensures better blood sugar control throughout the day, especially for patients with uncontrolled diabetes on monotherapy.\n\nUses of GLIDAPA TENMET 500\n\nGLIDAPA TENMET 500 is primarily prescribed for:\n\nManagement of Type 2 Diabetes Mellitus\nPatients with inadequate glycemic control on dual therapy\nReducing fasting and postprandial blood glucose levels\nImproving insulin sensitivity\nSupporting weight management in diabetic patients\n\nIt is usually recommended along with a proper diet and regular exercise for optimal results.\n\nKey Benefits of GLIDAPA TENMET 500\n1. Triple Mechanism Action\n\nUnlike single or dual therapy drugs, this combination provides a three-way approach to diabetes control, targeting different physiological processes.\n\n2. Effective Blood Sugar Control\n\nIt helps maintain stable glucose levels throughout the day, reducing spikes after meals.\n\n3. Weight Management Support\n\nDapagliflozin aids in calorie loss through urine, which may help in weight reduction.\n\n4. Cardiovascular Benefits\n\nThis combination may help reduce cardiovascular risks associated with diabetes when used under medical supervision.\n\n5. Low Risk of Hypoglycemia\n\nCompared to some other antidiabetic medications, it has a relatively lower risk of causing dangerously low blood sugar levels.\n\n6. Improved Patient Compliance\n\nCombining three drugs in one tablet reduces pill burden and improves adherence.\n\nDosage and Administration\nTake GLIDAPA TENMET 500 as prescribed by your doctor\nUsually taken once daily with meals to reduce gastrointestinal side effects\nSwallow the tablet whole; do not crush or chew\nFollow your physician’s advice strictly for best results\nSide Effects of GLIDAPA TENMET 500\n\nLike all medications, this combination may cause some side effects. Most are mild and temporary.\n\nCommon Side Effects\nNausea or vomiting\nDiarrhea\nHeadache\nIncreased urination\nNasopharyngitis (cold-like symptoms)\nMild dehydration\nSerious Side Effects (Rare)\nUrinary tract infections\nGenital infections\nLactic acidosis (rare but serious, linked to Metformin)\nHypoglycemia (especially if combined with other medications)\nKidney function changes\n\nIf any severe symptoms occur, immediate medical attention is necessary.\n\nPrecautions and Warnings\nNot recommended for patients with severe kidney disease\nUse cautiously in elderly patients\nAvoid excessive alcohol consumption\nInform your doctor if you have liver, heart, or pancreatic conditions\nNot suitable for type 1 diabetes or diabetic ketoacidosis\n\nPregnant and breastfeeding women should consult a healthcare professional before use.\n\nWho Should Use GLIDAPA TENMET 500?\n\nThis medication is ideal for:\n\nAdults diagnosed with Type 2 Diabetes\nPatients requiring combination therapy\nIndividuals not achieving control with Metformin alone\nOverweight diabetic patients needing additional metabolic benefits\nStorage Instructions\nStore in a cool, dry place\nKeep away from direct sunlight and moisture\nKeep out of reach of children\nConclusion\n\nGLIDAPA TENMET 500 is a modern, highly effective triple-combination therapy designed to provide comprehensive control over type 2 diabetes. With the combined power of Dapagliflozin, Teneligliptin, and Metformin Hydrochloride, it addresses multiple aspects of glucose metabolism, making it a preferred choice for healthcare professionals.\n\nIts benefits go beyond just blood sugar control—it also supports weight management, improves insulin sensitivity, and enhances overall metabolic health. However, like any medication, it should only be used under proper medical supervision to ensure safety and effectiveness.",
"price": 182.0,
"discountamount": 55.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2369,
"imageuri": "https://productimages.withfloats.com/actual/69d4f4b2203d41ae56676abb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69d4f4b2203d41ae56676abb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-04-07T12:12:31.371Z",
"updatedon": "2026-04-14T12:54:05.267Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-10-mg-teneligliptin-20-mg-metformin-hydrochloride-500-mg-extended-release-tablets/2369",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIDAPA TENMET 500",
"category": "DIABETIC RANGE",
"tags": [
"dapagliflozin teneligliptin metformin combination uses",
"metformin teneligliptin dapagliflozin tablets for type 2 diabetes",
"buy dapagliflozin teneligliptin metformin tablets online India",
"dapagliflozin teneligliptin metformin tablet price wholesale",
"SGLT2 + DPP4 + Metformin combination tablet supplier",
"anti diabetic triple combination tablets wholesale",
"riple combination diabetes medicine manufacturer India"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "699bfe45e844b0fb29d2bbad",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Sitagliptin 100 Pioglitazone 15 Metformin 500",
"description": "Product Name: ST GLIPTIN 3D 500\nComposition: Sitagliptin 100 mg + Pioglitazone 15 mg + Metformin 500 mg\n\nST GLIPTIN 3D 500 is a scientifically formulated triple-combination oral antidiabetic tablet designed to help manage Type 2 Diabetes Mellitus effectively. This advanced formulation combines the proven benefits of Sitagliptin, Pioglitazone, and Metformin to provide comprehensive glycemic control through three complementary mechanisms of action.\n\nThis triple therapy approach is especially beneficial for patients whose blood glucose levels are not adequately controlled with dual therapy or monotherapy. ST GLIPTIN 3D 500 is developed to address multiple metabolic defects associated with Type 2 diabetes, ensuring better long-term glucose management and improved patient outcomes.\n\nProduct Description\n\nST GLIPTIN 3D 500 is an oral antidiabetic medication that works by targeting different physiological pathways involved in glucose regulation:\n\nSitagliptin 100 mg enhances incretin hormone levels, which increase insulin release and decrease glucagon secretion in a glucose-dependent manner.\n\nPioglitazone 15 mg improves insulin sensitivity in muscle and adipose tissues, allowing the body to use insulin more effectively.\n\nMetformin 500 mg reduces hepatic glucose production and improves peripheral glucose uptake.\n\nBy combining these three well-established agents into a single tablet, ST GLIPTIN 3D 500 simplifies diabetes management while improving adherence and therapeutic efficiency.\n\nUses of ST GLIPTIN 3D 500\n\nST GLIPTIN 3D 500 is primarily indicated for:\n\nManagement of Type 2 Diabetes Mellitus\n\nImproving glycemic control in adults\n\nPatients inadequately controlled on metformin alone\n\nIndividuals requiring triple oral therapy\n\nReducing fasting and postprandial blood glucose levels\n\nSupporting long-term HbA1c reduction\n\nIt is typically prescribed alongside lifestyle modifications such as a healthy diet, regular exercise, and weight management.\n\nHow ST GLIPTIN 3D 500 Works\n\nType 2 diabetes is characterized by insulin resistance, decreased insulin secretion, and excessive hepatic glucose production. ST GLIPTIN 3D 500 addresses all three core defects:\n\nEnhances insulin secretion (Sitagliptin) – Works in a glucose-dependent manner, reducing risk of hypoglycemia.\n\nImproves insulin sensitivity (Pioglitazone) – Helps the body respond better to insulin.\n\nReduces glucose production (Metformin) – Decreases sugar release from the liver.\n\nThis comprehensive mechanism makes ST GLIPTIN 3D 500 a powerful therapeutic option for sustained glycemic control.\n\nKey Benefits of ST GLIPTIN 3D 500\n1. Triple Mechanism Advantage\n\nCombines three different classes of antidiabetic agents for broader and more effective blood sugar management.\n\n2. Improved HbA1c Reduction\n\nHelps significantly lower HbA1c levels when compared to monotherapy.\n\n3. Reduced Pill Burden\n\nThree medications in one tablet improve patient compliance and convenience.\n\n4. Better Postprandial Control\n\nHelps manage blood glucose spikes after meals.\n\n5. Insulin Sensitivity Enhancement\n\nPioglitazone improves peripheral glucose utilization.\n\n6. Lower Risk of Hypoglycemia\n\nSitagliptin works in a glucose-dependent manner, minimizing low blood sugar risk when used appropriately.\n\n7. Suitable for Long-Term Management\n\nDesigned for chronic use under medical supervision.\n\nDosage and Administration\n\nThe dosage should be taken strictly as prescribed by a healthcare professional.\n\nUsually administered once daily with meals to reduce gastrointestinal discomfort.\n\nSwallow the tablet whole with water.\n\nDo not crush or chew unless directed by a doctor.\n\nRegular monitoring of blood glucose and HbA1c levels is recommended during therapy.\n\nPossible Side Effects\n\nLike all medications, ST GLIPTIN 3D 500 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects:\n\nNausea\n\nDiarrhea\n\nStomach discomfort\n\nHeadache\n\nUpper respiratory symptoms\n\nLess Common but Important:\n\nWeight gain (associated with Pioglitazone)\n\nFluid retention or edema\n\nLow blood sugar (when combined with other antidiabetic agents)\n\nVitamin B12 deficiency (long-term Metformin use)\n\nRare but Serious:\n\nLactic acidosis (rare, associated with Metformin)\n\nPancreatitis (rare, associated with Sitagliptin)\n\nLiver function abnormalities\n\nPatients should immediately consult a healthcare provider if they experience severe abdominal pain, persistent vomiting, unusual swelling, or breathing difficulties.\n\nPrecautions and Warnings\n\nNot recommended for Type 1 diabetes.\n\nUse cautiously in patients with renal impairment.\n\nLiver function monitoring may be required.\n\nAvoid excessive alcohol consumption.\n\nInform your doctor about any existing heart conditions.\n\nPregnant or breastfeeding women should use this medication only if clearly advised by a healthcare professional.\n\nStorage Instructions\n\nStore below 25°C in a dry place.\n\nKeep away from direct sunlight.\n\nKeep out of reach of children.\n\nWhy Choose ST GLIPTIN 3D 500?\n\nST GLIPTIN 3D 500 stands out as a comprehensive diabetes management solution by combining three powerful and clinically established molecules in one convenient tablet. It is particularly beneficial for patients who require intensified glycemic control without increasing pill burden.\n\nThe triple therapy model helps target multiple metabolic dysfunctions simultaneously, offering better blood glucose stability throughout the day. When used as part of a complete diabetes management plan—including diet, exercise, and routine monitoring—ST GLIPTIN 3D 500 can significantly enhance quality of life and reduce long-term complications associated with uncontrolled diabetes.\n\nConclusion\nST GLIPTIN 3D 500 (Sitagliptin 100 mg + Pioglitazone 15 mg + Metformin 500 mg) represents a modern, evidence-based approach to managing Type 2 Diabetes Mellitus. By addressing insulin resistance, impaired insulin secretion, and excessive glucose production, it provides comprehensive and sustained glycemic control.",
"price": 222.0,
"discountamount": 67.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2311,
"imageuri": "https://productimages.withfloats.com/actual/699bfe47d849febb9bcc2d46.png",
"tileimageuri": "https://productimages.withfloats.com/tile/699bfe47d849febb9bcc2d46.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-02-23T07:14:13.494Z",
"updatedon": "2026-03-13T11:04:02.141Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//sitagliptin-100-pioglitazone-15-metformin-500/2311",
"availableunits": -1.0,
"iscodavailable": true,
"isprepaidonlineavailable": true,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ST GLIPTIN 3D 500",
"category": "DIABETIC RANGE",
"tags": [
"Sitagliptin 100 Pioglitazone 15 Metformin 500 tablet uses",
"Sitagliptin Pioglitazone Metformin triple therapy dosage",
"Sitagliptin 100 mg Pioglitazone 15 mg Metformin 500 mg benefits",
"Triple combination tablet for type 2 diabetes control",
"Sitagliptin Pioglitazone Metformin side effects in adults",
"How to take Sitagliptin Pioglitazone Metformin tablet",
"Sitagliptin Metformin Pioglitazone price in India",
"Buy Sitagliptin 100 Pioglitazone 15 Metformin 500 online",
"Order Sitagliptin Pioglitazone Metformin tablets",
"Sitagliptin 100 Pioglitazone 15 Metformin 500 price",
"Sitagliptin triple combination bulk purchase"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6979b09d927481ba212bc573",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Tedizolid Phosphate 200 mg ",
"description": "TEDIZOLINE 200 is a state-of-the-art pharmaceutical formulation containing Tedizolid Phosphate 200 mg, representing a significant advancement in the treatment of serious bacterial skin infections. This next-generation oxazolidinone antibiotic offers a powerful solution for patients battling acute bacterial skin and skin structure infections (ABSSSI), including those caused by methicillin-resistant Staphylococcus aureus (MRSA) and other resistant bacterial strains. Developed to address the growing challenge of antibiotic resistance, TEDIZOLINE 200 provides healthcare professionals with an effective therapeutic option when conventional antibiotics may fall short.\nThe active ingredient, Tedizolid Phosphate, functions as a prodrug that is rapidly converted in the body to its active form, tedizolid. This sophisticated mechanism ensures optimal bioavailability and targeted antibacterial action. Each tablet of TEDIZOLINE 200 delivers a precise 200 mg dose, carefully calibrated to provide maximum efficacy while minimizing the risk of adverse effects. The medication is available in convenient oral tablet form, offering flexibility in treatment administration and improving patient compliance compared to intravenous-only alternatives.\nClinical Applications and Therapeutic Uses\nTEDIZOLINE 200 is specifically indicated for the treatment of acute bacterial skin and skin structure infections caused by susceptible strains of various gram-positive bacteria. These infections include cellulitis, major cutaneous abscesses, and wound infections that require systemic antibiotic therapy. The medication demonstrates exceptional efficacy against problematic pathogens including Staphylococcus aureus (both methicillin-susceptible and methicillin-resistant strains), various Streptococcus species, and Enterococcus faecalis.\nHealthcare providers prescribe TEDIZOLINE 200 when patients present with complicated skin infections characterized by significant inflammation, purulent discharge, or systemic signs of infection such as fever and elevated white blood cell counts. The medication is particularly valuable in hospital settings where antibiotic-resistant organisms pose significant treatment challenges, though it is equally effective for outpatient management of appropriate cases.\nThe standard treatment duration with TEDIZOLINE 200 is notably shorter than many traditional antibiotics, typically requiring only six days of therapy. This abbreviated course represents a significant advantage, potentially improving patient adherence, reducing the risk of developing resistance, and minimizing healthcare costs while maintaining excellent clinical outcomes.\nKey Benefits and Therapeutic Advantages\nSuperior Antimicrobial Potency: TEDIZOLINE 200 exhibits exceptional bactericidal activity against resistant gram-positive organisms, making it a frontline weapon against infections that have failed to respond to first-line antibiotics. Its unique mechanism of action—inhibiting bacterial protein synthesis by binding to the 23S ribosomal RNA of the 50S subunit—prevents bacteria from producing essential proteins necessary for survival and reproduction.\nShortened Treatment Duration: Unlike conventional antibiotics that may require ten to fourteen days of therapy, TEDIZOLINE 200 achieves comparable or superior outcomes with just six days of treatment. This condensed regimen reduces the pill burden for patients, improves treatment completion rates, and decreases the opportunity for resistance development.\nFlexible Administration Options: The medication offers both oral and intravenous formulations with nearly identical bioavailability, allowing seamless transitions between routes of administration. This flexibility enables early hospital discharge with continuation of oral therapy at home, reducing healthcare costs and improving patient comfort and quality of life.\nOnce-Daily Dosing Convenience: TEDIZOLINE 200's pharmacokinetic profile supports convenient once-daily administration, simplifying treatment schedules and enhancing patient compliance. The sustained therapeutic levels achieved with this dosing frequency ensure continuous antibacterial activity throughout the treatment course.\nReduced Drug Interaction Profile: Compared to its predecessor oxazolidinone antibiotics, TEDIZOLINE 200 demonstrates minimal interactions with dietary tyramine and requires less stringent dietary restrictions. Additionally, it exhibits reduced potential for serotonin syndrome, offering improved safety when used in patients taking certain antidepressants or other serotonergic medications.\nProven Clinical Efficacy: Extensive clinical trials have demonstrated that TEDIZOLINE 200 achieves cure rates comparable to or exceeding those of vancomycin and linezolid, the traditional gold standards for treating MRSA infections. These studies confirm both the non-inferiority and, in some parameters, the superiority of tedizolid phosphate in treating complicated skin infections.\nPotential Side Effects and Safety Considerations\nWhile TEDIZOLINE 200 is generally well-tolerated, patients and healthcare providers should be aware of potential adverse effects. The most commonly reported side effects include nausea, headache, diarrhea, and vomiting, which typically manifest as mild to moderate in severity and often resolve without intervention.\nGastrointestinal disturbances affect approximately five to ten percent of patients, with nausea being the most frequent complaint. Taking the medication with food may help minimize these symptoms without compromising absorption. Headaches occur in a similar percentage of patients and usually respond well to over-the-counter analgesics.\nMore serious but less common adverse effects include myelosuppression, manifesting as decreased blood cell counts. Although TEDIZOLINE 200 demonstrates less bone marrow suppression than older oxazolidinones, monitoring of complete blood counts is recommended for treatment courses extending beyond the standard six days or in patients with pre-existing hematologic conditions.\nPeripheral and optic neuropathy have been reported with prolonged oxazolidinone use, though the shorter treatment duration of TEDIZOLINE 200 substantially reduces this risk. Patients should report any vision changes, numbness, tingling, or weakness in extremities promptly to their healthcare provider.\nClostridium difficile-associated diarrhea can occur with virtually any antibiotic, including TEDIZOLINE 200. Patients experiencing severe, persistent, or bloody diarrhea during or following treatment should seek immediate medical attention.\nHypersensitivity reactions, though rare, may occur and can range from mild rash to severe anaphylaxis. Any signs of allergic reaction warrant immediate discontinuation and appropriate medical intervention.\nConclusion\nTEDIZOLINE 200 represents a significant therapeutic advancement in the management of acute bacterial skin and skin structure infections, particularly those involving antibiotic-resistant organisms. Its potent antimicrobial activity, convenient once-daily dosing, shortened treatment duration, and improved safety profile compared to earlier oxazolidinones make it an invaluable addition to the antimicrobial arsenal. The medication addresses critical unmet needs in infectious disease management, offering effective treatment options when traditional antibiotics prove insufficient.",
"price": 1250.0,
"discountamount": 375.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2288,
"imageuri": "https://productimages.withfloats.com/actual/6979b0c4b75d7c0b79b08e15.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6979b0c4b75d7c0b79b08e15.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-01-28T06:45:49.837Z",
"updatedon": "2026-04-17T11:40:48.569Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//tedizolid-phosphate-200-mg-/2288",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TEDIZOLINE 200",
"category": "DERMATALOGY",
"tags": [
"tedizolid phosphate 200 mg tablet",
"tedizolid phosphate 200 mg uses",
"tedizolid phosphate 200 mg dosage",
"tedizolid phosphate tablets 200 mg price",
"tedizolid phosphate 200 mg side effects",
"tedizolid phosphate 200 mg brand name",
"tedizolid phosphate 200 mg mechanism of action",
"buy tedizolid phosphate 200 mg tablet",
"tedizolid phosphate 200 mg prescription info",
"tedizolid phosphate 200 mg tablet details",
"tedizolid phosphate 200 mg for skin infection",
"tedizolid phosphate 200 mg once daily tablet",
"tedizolid phosphate 200 mg tablet working"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "694004d8504825bb23fa3c1f",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Terbinafine and Itraconazole Tablets 250/100 mg",
"description": "CONARIS T100 is a potent antifungal medication formulated with Terbinafine 250 mg and Itraconazole 100 mg. This combination tablet is designed to treat a wide range of fungal infections affecting the skin, nails, and other body parts. Terbinafine and Itraconazole work synergistically to eliminate fungi effectively by targeting their cell membranes and inhibiting growth, providing faster relief from symptoms such as itching, redness, scaling, and discomfort.\n\nFungal infections are common in humid climates and among individuals with compromised immunity, and medications like CONARIS T100 are essential for managing stubborn and recurrent infections. This combination therapy is often prescribed by dermatologists and healthcare professionals for moderate to severe fungal conditions.\n\nUses\n\nCONARIS T100 is used in the treatment of several fungal infections, including:\n\nDermatophytosis (Ringworm): Effective against infections of the skin, hair, and nails caused by dermatophytes.\n\nOnychomycosis (Nail Fungus): Helps in treating fungal infections of fingernails and toenails.\n\nTinea Infections: Treats tinea corporis, tinea cruris, and tinea pedis (athlete’s foot).\n\nCandidiasis: Useful in managing Candida infections affecting the skin and mucous membranes.\n\nRecurrent or Resistant Fungal Infections: Provides stronger antifungal action in cases not responsive to monotherapy.\n\nBenefits\n1. Broad-Spectrum Antifungal Action\n\nThe combination of Terbinafine and Itraconazole ensures effective activity against a wide variety of fungal species, including dermatophytes and yeasts.\n\n2. Faster Symptom Relief\n\nBy targeting fungi at multiple levels, CONARIS T100 helps relieve itching, redness, scaling, and discomfort more quickly than single-agent therapy.\n\n3. Treats Nail and Skin Infections\n\nTerbinafine penetrates nails effectively, while Itraconazole enhances the antifungal spectrum, making the combination ideal for nail and skin fungal infections.\n\n4. Reduces Recurrence\n\nCombination therapy decreases the risk of fungal infections returning by ensuring complete eradication of the pathogen.\n\n5. Convenient Dosage Form\n\nAvailable as an oral tablet, making it easy to administer and suitable for long-term treatment if prescribed.\n\nDosage\n\nAdults: Usually, one tablet of CONARIS T100 daily, preferably after meals, or as directed by a healthcare professional.\n\nTreatment Duration: Varies depending on the type and severity of infection; may range from 2 to 12 weeks for skin infections and longer for nail infections.\n\nImportant: Do not self-adjust dosage or stop treatment prematurely, as incomplete therapy can lead to recurrence or resistance.\n\nSide Effects\n\nCONARIS T100 is generally well tolerated when used as prescribed. Mild side effects may include:\n\nNausea or vomiting\n\nStomach upset or diarrhea\n\nHeadache\n\nDizziness\n\nSerious Side Effects (Rare)\n\nLiver enzyme elevation (monitoring recommended for long-term use)\n\nAllergic reactions such as rash, itching, or swelling\n\nSevere gastrointestinal discomfort\n\nConsult a healthcare provider immediately if you experience jaundice, persistent fatigue, or severe allergic reactions.\n\nPrecautions and Warning\n\nPregnancy and Breastfeeding: Use only if prescribed by a doctor; safety during pregnancy is not fully established.\n\nLiver or Kidney Disorders: Dose adjustment or close monitoring may be required.\n\nDrug Interactions: Inform your doctor about all medications, especially antifungals, statins, or anticoagulants.\n\nAvoid Self-Medication: Fungal infections may mimic other skin conditions, so proper diagnosis is essential.\n\nAlcohol Consumption: Avoid alcohol as it may increase liver toxicity risk.\n\nStorage: Store in a cool, dry place away from direct sunlight and out of children’s reach.\n\nConclusion\n\nCONARIS T100, containing Terbinafine 250 mg and Itraconazole 100 mg, is a reliable and effective treatment for a wide spectrum of fungal infections, including skin, nail, and mucosal infections. Its dual-action antifungal mechanism provides faster symptom relief, reduces recurrence, and improves overall patient outcomes.\n\nWhen used under medical supervision and following prescribed dosage, CONARIS T100 offers a safe and convenient option for managing both common and stubborn fungal infections, ensuring better skin and nail health and enhanced quality of life.",
"price": 184.0,
"discountamount": 55.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2248,
"imageuri": "https://productimages.withfloats.com/actual/694004da351fe1d6b98476e6.png",
"tileimageuri": "https://productimages.withfloats.com/tile/694004da351fe1d6b98476e6.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-12-15T12:53:44.573Z",
"updatedon": "2026-03-12T07:12:53.163Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//terbinafine-and-itraconazole-tablets-250-100-mg/2248",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CONARIS T100",
"category": "DERMATALOGY",
"tags": [
"terbinafine and itraconazole tablets",
"terbinafine and itraconazole together",
"terbinafine and itraconazole tablets uses",
"terbinafine and itraconazole for nail fungus",
"terbinafine and itraconazole tablets uses",
"terbinafine itraconazole combination tablet",
"terbinafine itraconazole tablets for fungal infection",
"terbinafine itraconazole tablets composition",
"terbinafine and itraconazole tablets dosage",
"terbinafine itraconazole tablets price in india",
"terbinafine itraconazole tablets brand name",
"terbinafine and itraconazole tablets for ringworm",
"terbinafine itraconazole tablets for skin fungal infection",
"terbinafine itraconazole tablets for tinea infection",
"terbinafine itraconazole tablets for nail fungus",
"terbinafine itraconazole tablets how to use",
"terbinafine itraconazole tablets side effects",
"terbinafine itraconazole tablets benefits",
"terbinafine itraconazole tablets working mechanism",
"terbinafine itraconazole tablets manufacturer in india",
"terbinafine itraconazole tablets supplier",
"terbinafine itraconazole tablets wholesale",
"terbinafine itraconazole tablets pcd pharma"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "69400387893a9153e4bd58a8",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Terbinafine and Itraconazole Tablets 250/200mg",
"description": "CONARIS T200 is a potent antifungal combination tablet containing Terbinafine 250 mg and Itraconazole 200 mg, formulated to provide effective treatment for various fungal infections. Fungal infections of the skin, nails, and hair are common in India due to the hot and humid climate. These infections can cause itching, redness, scaling, and discomfort, affecting daily life and confidence.\n\nBy combining two powerful antifungal agents, CONARIS T200 targets fungal infections effectively, providing faster relief and improved recovery compared to monotherapy. Terbinafine works by inhibiting fungal cell growth, while Itraconazole disrupts fungal cell membrane formation, resulting in a comprehensive antifungal effect.\n\nUses\n\nCONARIS T200 is primarily prescribed for the management of:\n\nDermatophytosis (Ringworm, Tinea Infections)\nTreats fungal infections affecting skin, nails, and scalp.\n\nOnychomycosis (Fungal Nail Infection)\nHelps in eliminating nail fungus and promotes healthy nail growth.\n\nCandidiasis (Yeast Infections)\nEffective against mucocutaneous and superficial candidal infections.\n\nOther Superficial Fungal Infections\nUseful in treating skin infections caused by dermatophytes, yeasts, and other fungi.\n\nThis combination is particularly beneficial for chronic, resistant, or recurrent fungal infections.\n\nBenefits\n1. Broad-Spectrum Antifungal Activity\n\nThe dual action of Terbinafine and Itraconazole ensures effectiveness against a wide range of fungi, providing comprehensive treatment.\n\n2. Faster Symptom Relief\n\nPatients experience reduced itching, redness, scaling, and discomfort sooner than with single antifungal therapy.\n\n3. Promotes Healing\n\nSupports the restoration of healthy skin and nails, improving appearance and comfort.\n\n4. Reduces Recurrence\n\nThe combination therapy helps prevent fungal infections from returning, especially in chronic or resistant cases.\n\n5. Convenient Oral Administration\n\nOnce- or twice-daily tablet dosing improves patient compliance compared to topical treatments.\n\n6. Suitable for Adults\n\nFormulated for adult patients suffering from persistent fungal infections that require systemic therapy.\n\nDosage\n\nThe recommended dose of CONARIS T200 is usually one tablet once daily, or as directed by a physician.\n\nDuration of therapy depends on the type and severity of infection:\n\nSkin infections: Typically 2–4 weeks\n\nNail infections: May require 6–12 weeks or longer for full recovery\n\nImportant Instructions:\n\nSwallow the tablet whole with water.\n\nTake the medicine after food to reduce stomach upset.\n\nDo not skip doses and complete the full course even if symptoms improve.\n\nAlways follow the prescribing doctor’s instructions to ensure optimal results.\n\nSide Effects\n\nCONARIS T200 is generally well-tolerated, but some patients may experience mild side effects:\n\nNausea and vomiting\n\nStomach discomfort or indigestion\n\nHeadache\n\nDizziness\n\nSerious but Rare Side Effects\n\nLiver function disturbances\n\nAllergic reactions such as rash or swelling\n\nSevere gastrointestinal discomfort\n\nIf any unusual or severe symptoms appear, consult a healthcare professional immediately.\n\nPrecautions and Warning\n\nLiver and Kidney Disorders: Use with caution; liver function tests may be recommended during therapy.\n\nPregnancy and Breastfeeding: Consult your doctor before use; safety has not been fully established.\n\nDrug Interactions: Inform your doctor about other medications, particularly antacids, anticoagulants, or statins.\n\nAllergy: Avoid if allergic to Terbinafine, Itraconazole, or any other ingredient in the tablet.\n\nAlcohol Consumption: Limit alcohol intake, as it may increase the risk of liver-related side effects.\n\nConclusion\n\nCONARIS T200 (Terbinafine 250 mg + Itraconazole 200 mg) is an effective and trusted antifungal combination for the treatment of a variety of superficial and chronic fungal infections. By targeting fungi through dual mechanisms, it provides faster relief, promotes healing, and helps prevent recurrence. With proper dosing, adherence to medical advice, and monitoring for side effects, CONARIS T200 offers a comprehensive solution for adults dealing with persistent fungal infections, helping restore healthy skin, nails, and overall comfort.",
"price": 204.0,
"discountamount": 61.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2247,
"imageuri": "https://productimages.withfloats.com/actual/69400389f34633ae3de3f8f4.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69400389f34633ae3de3f8f4.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-12-15T12:48:07.707Z",
"updatedon": "2026-03-12T07:12:03.519Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//terbinafine-and-itraconazole-tablets-250-200mg/2247",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CONARIS T200",
"category": "DERMATALOGY",
"tags": [
"terbinafine and itraconazole tablets",
"terbinafine and itraconazole",
"terbinafine and itraconazole combination",
"terbinafine and itraconazole together",
"Fungal infections of the skin",
"helping restore healthy skin"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6911af10f122e2a45d230b07",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg & Glimepirde 2 mg",
"description": "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 2 mg is a triple-combination oral anti-diabetic medication formulated to achieve optimal blood sugar control in adults with Type 2 Diabetes Mellitus (T2DM). This unique blend brings together three complementary agents — Sitagliptin (a DPP-4 inhibitor), Metformin (a biguanide), and Glimepiride (a sulfonylurea) — that work through distinct mechanisms to enhance glucose regulation, improve insulin sensitivity, and support overall metabolic balance.\n\nThis advanced combination therapy is prescribed when monotherapy or dual therapy fails to achieve adequate glycemic control. It helps reduce both fasting plasma glucose (FPG) and postprandial glucose (PPG) levels, promoting stable long-term glycemic management.\n\nUses of Sitagliptin + Metformin + Glimepiride\n\nThis fixed-dose combination is primarily indicated for the management of Type 2 Diabetes Mellitus in adults. It is especially beneficial for patients whose blood sugar levels remain uncontrolled despite treatment with Metformin and Glimepiride or Metformin and Sitagliptin alone.\n\nIts main objectives include:\n\nControlling elevated blood glucose levels in adults with Type 2 diabetes\n\nReducing the risk of diabetes-related complications such as neuropathy, nephropathy, and cardiovascular diseases\n\nSupporting better insulin utilization by the body\n\nComplementing diet, exercise, and lifestyle modification to maintain optimal glycemic balance\n\nMechanism of Action\n\nEach component of this combination plays a vital role in maintaining blood sugar control:\n\nSitagliptin (50 mg) – A Dipeptidyl Peptidase-4 (DPP-4) inhibitor that enhances the activity of incretin hormones. These hormones stimulate insulin release and suppress glucagon production when blood glucose levels rise, thereby improving post-meal glucose control.\n\nMetformin Hydrochloride (1000 mg) – A biguanide that lowers glucose production in the liver and increases the body’s sensitivity to insulin. It also decreases intestinal glucose absorption, making it an essential first-line therapy in diabetes management.\n\nGlimepiride (2 mg) – A sulfonylurea that stimulates pancreatic beta cells to release more insulin, especially when blood glucose levels are high. It works synergistically with Metformin and Sitagliptin for more effective glycemic control.\n\nKey Benefits\n\nTriple Mechanism for Superior Control:\nBy combining three potent agents, the medication addresses multiple pathways of glucose regulation—insulin secretion, insulin sensitivity, and hepatic glucose output—resulting in comprehensive and consistent control of blood sugar levels.\n\nEffective Glycemic Stability:\nThe combination helps maintain target HbA1c levels and reduces both fasting and post-meal glucose spikes without significant weight gain when used with proper diet and exercise.\n\nReduced Risk of Diabetic Complications:\nLong-term blood sugar control minimizes the risk of complications such as kidney disease, vision problems, nerve damage, and heart conditions associated with uncontrolled diabetes.\n\nConvenient Fixed-Dose Formulation:\nCombining three medications into a single tablet simplifies dosing schedules, improves patient adherence, and reduces pill burden, which is crucial for long-term treatment success.\n\nImproved Insulin Efficiency:\nEnhances the body's natural insulin response and glucose metabolism, allowing for smoother daily energy levels and reduced fatigue associated with hyperglycemia.\n\nPossible Side Effects\n\nWhile this combination is generally well tolerated, some patients may experience side effects, especially at the beginning of therapy. Common and rare side effects include:\n\nHypoglycemia (low blood sugar): More likely when meals are skipped or during excessive physical exertion. Symptoms include sweating, dizziness, and rapid heartbeat.\n\nGastrointestinal disturbances: Such as nausea, vomiting, diarrhea, abdominal discomfort, or loss of appetite (mostly due to Metformin).\n\nHeadache or Weakness: Usually mild and transient.\n\nAllergic reactions: Rarely, rash or itching may occur.\n\nLactic Acidosis (rare but serious): A potential complication of Metformin, particularly in patients with kidney impairment or excessive alcohol consumption.\n\nWeight gain: Mild weight gain may occur due to Glimepiride’s insulin-enhancing effect.\n\nPrecautions:\n\nRegular monitoring of blood sugar levels and kidney function is essential.\n\nAvoid alcohol and consult a doctor before using this medicine if you have liver or kidney disease.\n\nThe medication should not be used in patients with Type 1 diabetes or diabetic ketoacidosis.\n\nConclusion\n\nThe combination of Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 2 mg represents a powerful and balanced therapy for adults with Type 2 Diabetes Mellitus, especially those requiring triple-drug intervention to achieve desired glycemic control. Its multi-targeted approach ensures effective management of both fasting and postprandial glucose levels, thereby improving long-term metabolic health and reducing the risk of complications.",
"price": 295.0,
"discountamount": 89.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2197,
"imageuri": "https://productimages.withfloats.com/actual/6911af137e4c90e1dc453884.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6911af137e4c90e1dc453884.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-11-10T09:23:28.795Z",
"updatedon": "2026-03-13T10:41:32.995Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//sitagliptin-50-mg-metformin-hydrochloride-1000-mg-glimepirde-2-mg/2197",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ST GLIPTIN GM 50+1000+2 ",
"category": "DIABETIC RANGE",
"tags": [
"Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 2 mg",
"anti-diabetic medication",
"blood sugar control",
"Type 2 Diabetes Mellitus"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}